Volume | 480,632 |
|
|||||
News | - | ||||||
Day High | 39.82 | Low High |
|||||
Day Low | 38.05 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Arcturus Therapeutics Holdings Inc | ARCT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
38.52 | 38.05 | 39.82 | 38.81 | 38.48 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
9,058 | 480,632 | US$ 39.02 | US$ 18,754,733 | - | 17.52 - 43.81 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:25:06 | 6 | US$ 39.56 | USD |
Arcturus Therapeutics Holdings Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.04B | 26.92M | - | 166.8M | -29.73M | -1.10 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Arcturus Therapeutics News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ARCT Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 31.03 | 39.82 | 30.27 | 37.32 | 596,158 | 7.78 | 25.07% |
1 Month | 27.64 | 39.82 | 26.28 | 31.23 | 480,114 | 11.17 | 40.41% |
3 Months | 35.99 | 39.82 | 25.41 | 31.48 | 516,952 | 2.82 | 7.84% |
6 Months | 24.54 | 43.81 | 22.35 | 32.33 | 458,861 | 14.27 | 58.15% |
1 Year | 26.57 | 43.81 | 17.52 | 29.89 | 438,459 | 12.24 | 46.07% |
3 Years | 29.60 | 64.9735 | 11.70 | 29.09 | 535,802 | 9.21 | 31.11% |
5 Years | 6.69 | 129.71 | 5.75 | 39.39 | 570,188 | 32.12 | 480.12% |
Arcturus Therapeutics Description
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of the company includes LUNAR-OTC, LUNAR-CF, and LUNAR-COV19. |